MedPage Today on MSN
Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer
SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...
13h
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
MedPage Today on MSN
Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm
SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...
BIRMINGHAM, AL, UNITED STATES, January 8, 2026 / EINPresswire.com / — Rampart, a Birmingham, Alabama–based medical device company redefining interventional radiation safety, today announced the launch ...
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving ...
The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
PsyPost on MSN
Blue-blocking glasses fail to alleviate mania
A new clinical trial conducted by researchers in Canada has found that wearing blue-blocking glasses did not significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback